This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Evercore ISI Sticks to Their Buy Rating for Medtronic (MDT)

Tipranks - Tipranks - Fri Jun 5, 8:28AM CDT

In a report released today, Vijay Kumar from Evercore ISI maintained a Buy rating on Medtronic, with a price target of $106.00.

Claim 55% Off TipRanks

Kumar covers the Healthcare sector, focusing on stocks such as Edwards Lifesciences, Boston Scientific, and Medtronic. According to TipRanks, Kumar has an average return of 1.3% and a 45.48% success rate on recommended stocks.

In addition to Evercore ISI, Medtronic also received a Buy from BTIG’s Ryan Zimmerman in a report issued today. However, on the same day, UBS reiterated a Hold rating on Medtronic (NYSE: MDT).

See Insiders’ Hot Stocks on TipRanks >>

Based on Medtronic’s latest earnings release for the quarter ending January 23, the company reported a quarterly revenue of $9.02 billion and a net profit of $1.14 billion. In comparison, last year the company earned a revenue of $8.29 billion and had a net profit of $1.29 billion

Read More on MDT:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).